A Revolutionary Road Map for Obesity Management and Beyond: Tirzepatide as a Dual-Acting Insulinotropic Polypeptide

Authors

  • Laith Thamer Al-Ameri Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0002-5863-1564
  • Ekhlas Khalid Hameed Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq https://orcid.org/0000-0002-0068-3329
  • Ziyad Dulaimi Madinat Zayed Hospital, Aldhafra, Abu Dhabi, UAE
  • Asgad Abdalgbar College of Medicine, Omar Al-Mukhtar University, Libya
  • May Yousif Wahdan Capio care center Hjortmossen, Sweden
  • Ali Al Joboory The Royal Melbourne Hospital, Melbourne, Australia
  • Sawsan Mahmoud Royal Columbian Hospital, New Westminster British Columbia, Canada
  • Maysaa Abdulla Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden https://orcid.org/0000-0002-0766-0656
  • Luay Alshara Weill Cornell Medical College – NY Presbyterian Hospital, USA
  • Nada Faisal Al-Dulaimi Universitätsklinikum Knappschaftskrankenhaus Bochum, Germany

DOI:

https://doi.org/10.47723/hesy7z38

Keywords:

Obesity, Diabetes Mellites, Metabolic disease, incretin hormones, GLP-1 , dyslipidemia

Abstract

Tirzepatide is a revolutionary and promising medication with a high impact in the treatment of Obesity and T2DM with their complications. Its efficacy was proven through different trials in achieving favorable weight loss and a significant reduction in glycemic index. It also treated a large diversity of related co-morbidities, including fatty liver, cardiovascular disease, dyslipidemia, and more. Tirzepatide is well tolerated, has a good safety profile, and is highly reliable and suitable for use in a population.

Downloads

Published

2024-12-01

Issue

Vol. 20 No. 3 (2024): Al-Kindy College Medical Journal

Section

Review Articles

License

Copyright (c) 2024 AL-Kindy College Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

1.
Al-Ameri LT, Hameed EK, Dulaimi Z, Abdalgbar A, Wahdan MY, Al Joboory A, et al. A Revolutionary Road Map for Obesity Management and Beyond: Tirzepatide as a Dual-Acting Insulinotropic Polypeptide. Al-Kindy Col. Med. J [Internet]. 2024 Dec. 1 [cited 2025 Jan. 5];20(3):158-62. Available from: https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/2060

Similar Articles

1-10 of 337

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>